Featured Research

from universities, journals, and other organizations

Smoking To Blame For More Than Half Of Difference In Men's Mortality Risk Across Class Lines

Date:
July 14, 2006
Source:
University of Toronto
Summary:
The direct correlation between lower socioeconomic status and mortality risk is well known, but a new study by the University of Toronto and the University of Oxford is the first to determine that more than half the difference in risk of death between men in the highest social strata and those in the lowest can be attributed to smoking.

The direct correlation between lower socioeconomic status and mortality risk is well known, but a new study by the University of Toronto and the University of Oxford is the first to determine that more than half the difference in risk of death between men in the highest social strata and those in the lowest can be attributed to smoking.

The study, which appears online in the Lancet's July 15 issue, looked at nearly 600,000 deaths in men aged 35 to 69 years in the U.K., Canada, U.S. and Poland.

"Across two continents, we find that smoking-related diseases account for well over half of the big difference in death rates between rich and poor," says study co-author Richard Peto, professor of medical statistics and epidemiology at the University of Oxford.

Researchers used an innovative, indirect method to estimate the contribution of smoking to mortality risk. The lung cancer deaths occurring in the different study groups were used as a guide to the respective proportions of deaths attributable to smoking in each group. Results were consistent across the five national populations studied.

Although mortality from smoking has recently started to decrease among men in Europe and North America, during the present decade smoking still accounts for about one-quarter of all male deaths in middle age. The study offers particular clarity to global and public health policy makers concerned with addressing the higher mortality rate among socially disadvantaged groups.

"These findings emphasize the importance of getting more smokers, especially in the lower socioeconomic bracket, to quit," says study co-author Professor Prabhat Jha of U of T's department of public health sciences, director of the Centre for Global Health Research at U of T and St. Michael's Hospital and Canada Research Chair in health and development.

"This means widespread cessation of smoking would do more than anything else to narrow the inequalities in health between rich and poor," says Jha.


Story Source:

The above story is based on materials provided by University of Toronto. Note: Materials may be edited for content and length.


Cite This Page:

University of Toronto. "Smoking To Blame For More Than Half Of Difference In Men's Mortality Risk Across Class Lines." ScienceDaily. ScienceDaily, 14 July 2006. <www.sciencedaily.com/releases/2006/07/060714082827.htm>.
University of Toronto. (2006, July 14). Smoking To Blame For More Than Half Of Difference In Men's Mortality Risk Across Class Lines. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2006/07/060714082827.htm
University of Toronto. "Smoking To Blame For More Than Half Of Difference In Men's Mortality Risk Across Class Lines." ScienceDaily. www.sciencedaily.com/releases/2006/07/060714082827.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins